Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
Quick Stats
Jan 30, 202647.6
AI Score
HOLD1.69
Volume Ratio
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
LTRN Stock Summary
Last updated Jan 30, 2026
LTRN is currently trading at $3.15, positioned below its 200-day moving average of $3.75, suggesting bearish momentum. The stock has a 52-week range of $2.55 to $5.7441.
Technical Analysis: The 50-day moving average stands at $3.43, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.117, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.309, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates LTRN at 47.6/100 with a HOLD recommendation.
LTRN (Lantern Pharma Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 42.117 |
| CMF (20) | 0.309 |
| ROC (10) | -10.256 |
| ADX (14) | 11.925 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.061 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -69.841 |
| MFI (14) | 43.179 |
LTRN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LTRN Price vs Max Options Open Interest
LTRN Max Change In Options Open Interest
LTRN Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LTRN Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LTRN Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LTRN Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Lantern Pharma Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LTRN Moving Averages Analysis
LTRN (Lantern Pharma Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.35 |
| 20 | 3.36 |
| 30 | 3.35 |
| 50 | 3.43 |
| 100 | 3.72 |
| 200 | 3.75 |
LTRN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 35.5 million |
| Earnings/Share ($) | -1.75 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.67 |
| EPS Estimate Next Year ($) | -1.525 |
| WallStreet Target Price ($) | 22 |
| Most Recent Quarter |